Cite

    Arianna Emiliozzi et al.. “Efficacy and safety of raltegravir in switch strategies in virologically suppressed patients: long-term data from clinical practice.” Journal of antimicrobial chemotherapy, vol. 74, 2019, pp. 2470–2472. http://access.bl.uk/ark:/81055/vdc_100176199051.0x000028